Clinical Investigation

Retropective analysis of 25 cases with borderline ovarian tumors


  • Şafak Yılmaz Baran
  • Behiye Pınar Çilesiz Göksedef
  • Hüsnü Görgen
  • Ahmet Çetin

Turk J Obstet Gynecol 2011;8(2):107-112


To determine the borderline ovarian tumors according to clinical features, treatment methods, recurrence and survival rates.

Material and Methods:

Twenty-five cases were included to this study. Demographic and clinical findings, surgical methods, stage of disease, recurrences and survivals were revealed from hospital records. Data were analyzed with SPSS 13.0.


Mean age were 42.7±17.9. Most of the patients were in premenopausal (n=19, 76%). Mean tumor size were 13.44±9.37 cm (range 4-30 cm) and 16 of the patients had serous and 9 of them had musinous histologic type. Mean tumor size of serous and mucinous tumors were 9.44±6.78 cm, 20.56±9.4 cm, respectively and the difference was statisticallly significant (p=0.007). Tumor markers were elevated in 17 of the patients (68%) before the surgery. Twenty-two patients had frozen section (88%), accuracy rate of the frozen section was 90%. during surgery. Most of the patients were treated with total abdominal hysterectomy bilateral salpingo-oophorectomy (TAH-BSO) (n=12), 6 of the patients were treated with cystectomy and the others were treated with unilateral oophorectomy (USO) (n=7). Most of the cases were stage I (n=23, 92%). Recurrence of the disease was detected in 4 patients (16%) and 2 of them were treated with cystectomy and the others were treated with USO. No recurrence was detected in TAH-BSO group.


Borderline tumors have perfect prognosis and most of the cases are premenopausal. The suggested treatment is surgical staging with TAH-BSO. Cystectomy might be chosen in young patients with fertilty desire, however, patients should be warned for high recurrence rates.

Keywords: borderline ovarian tumor, histologic type, tumor markers, recurrence, survival\r\n